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 Introduction
 The vascular NAD(P)H oxidase, a major source of re-
active oxygen species, is increasingly being implicated in 
the pathogenesis of vascular disease  [1, 2] . The p22 phox  
subunit, which is essential for the activation of NAD(P)H 
oxidase, showed enhanced expression in atherosclerotic 
vessel walls  [3] . A functional C-to-T substitution poly-
morphism of the regulatory p22 phox  subunit has been re-
ported to go along with a reduction in the generation of 
superoxide anions (O 2 –  ) in the vascular wall  [4] . Ultimate-
ly, this may lead to secondary dysfunctions, such as en-
hanced platelet adherence, intima proliferation or in-
flammation. Previous association studies revealed an in-
creased risk for and enhanced progression of coronary 
disease in subjects carrying this single-nucleotide poly-
morphism (SNP)  [5, 6] . However, conflicting findings 
have been published, with some researchers reporting a 
protective effect of the T allele in coronary artery disease. 
Moreover, no association of the C242T genotype and oth-
er p22 phox  polymorphisms with cerebral small-vessel dis-
ease was detected in a recent study  [7] . In a Japanese pop-
ulation, the TC and TT genotypes showed an association 
with stroke or transient ischemic attack  [8] . Nevertheless, 
we guess that the explanatory power of these previous 
studies may be limited on account of confounding factors 
in an aged patient population. Therefore, in this study we 
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 Abstract
 Background and Purpose: Oxidative stress has been pro-
posed as a major contributing factor for vascular disease, 
that acts independently from its participation in predispos-
ing disorders such as diabetes and arterial hypertension. A 
functionally relevant C242T polymorphism of the  CYBA gene 
encoding the NAD(P)H oxidase p22 phox  subunit, is supposed 
to lead to an abnormal reduction in the generation of reac-
tive oxygen species in vascular smooth-muscle and endo-
thelial cells.  Methods: We investigated the p22 phox  C242T 
single-nucleotide polymorphism by polymerase chain reac-
tion in consecutive patients with ischemic stroke or transient 
ischemic attack under the age of 50 (n = 161) and in popula-
tion-based control subjects (n = 136).  Results: Homozygos-
ity for the T variant was associated with an enhanced risk for 
cerebral ischemia (odds ratio 3.85, confidence interval 1.39–
10.64) after adjusting for classical risk factors. Risk for cere-
bral ischemia was not increased in heterozygous subjects. 
 Conclusion: The p22 phox  C242T single-nucleotide polymor-
phism is associated with stroke risk. This finding supports 
the hypothesis that oxidative stress may contribute to stroke 
pathogenesis.  Copyright © 2008 S. Karger AG, Basel
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sought to investigate the association of the p22 phox  geno-
type with cerebrovascular disease (CVD) in a well-char-
acterized group of juvenile stroke patients.
 Methods
 We investigated 161 patients aged less than 50 years (40.4  8 
7.6) who were consecutively admitted to our university hospital 
with a diagnosis of ischemic stroke (n = 112) or transient ischemic 
attack (n = 49). All patients received a computed coronal tomog-
raphy or magnetic resonance imaging scan and a full clinical 
workup. This included extra- and intracranial ultrasound studies 
and a search for cardiac sources of embolism, right-to-left shunt 
and digital arterial angiography, where appropriate. Etiological 
subgroups were defined as follows: (1) large-artery atherosclerosis 
(n = 34), defined as stenosis of 50% diameter reduction; (2) car-
diac embolism (n = 35), defined following the Trial of Org 10172 
in Acute Stroke Treatment criteria of cardiac embolism  [9] and 
additionally including persistent foramen ovale, as diagnosed by 
transesophageal echocardiogram and ultrasound studies; (3) dis-
section of brain-supplying arteries (n = 30), as diagnosed by ul-
trasound and magnetic resonance imaging or digital subtraction 
angiography; (4) cryptogenic embolism (n = 50), and (5) others 
(n = 12), including cerebral microangiopathy and vasculitis. A 
 total of 136 control subjects (aged 34.3  8 9.5 years) without a his-
tory of vascular disease were randomly selected from the popula-
tion registries of the same region in southwest Germany and were 
contacted by mail. The participation rate of eligible patients was 
99.5%, and that of control subjects was 65%. Patients or controls 
of non-German descent or who were unable to undergo a stan-
dardized interview that focused on risk factors of vascular disease 
were excluded. The study was approved by the local ethics board, 
and all subjects gave written informed consent. The C242T poly-
morphism of the p22 phox  gene was detected by polymerase chain 
reaction (PCR) amplification from genomic DNA, employing the 
forward primer 5  -CGCTGGCGTCCGGCCTGATCCTCA-3  
and the reverse primer 5  -ACGCACAGCCGCCAGTAGGTAG-
AT-3  ; subsequently the PCR products were digested by incuba-
tion with the restriction endonuclease  Rsa I. Fragments were de-
tected by electrophoresis on a 2.5% agarose gel stained with 0.1% 
ethidium bromide. Amplification products of the wild type of the 
single-nucleotide polymorphism yielded an unrestricted amplifi-
cation product of 348 bp. Heterozygous subject DNA digestion led 
to 3 fragments of 348, 188 and 160 bp in length, while TT geno-
types yielded fragments sized 188 and 160 bp. Demographic and 
clinical variables were compared by Fisher’s exact test, or t test as 
appropriate. Genotype and allele frequencies were compared by a 
pairwise comparison of the genotypes using a binary logistic re-
gression correcting for age, arterial hypertension, diabetes mel-
litus and smoking.
 Results
 The demographic variables and prevalence of major 
vascular risk factors are presented in  table 1 . Patients suf-
fered more often from hypertension and diabetes melli-
tus and were somewhat older than control subjects. The 
TT genotype of the C242T polymorphism of the p22 phox  
gene was significantly more prevalent in the group of ju-
venile CVD patients than in the control group (p = 0.009 
when compared to the CC/CT genotype;  table 2 ) result-
 Table 1. Demographic characteristics of the study population and prevalence of conventional vascular risk fac-
tors
 Control group
 (n = 136) 
 Patients
 (n = 161) 
 Odds ratio
 (95% CI) 
p value 
 Age, years  34.3 8 9.5  40.4 8 7.6  <0.001 1 
 Male sex 70 (51.4%) 95 (59%)  1.35 (0.85–2.15) 0.19 
 Hypertension 8 (5.8%) 54 (33.5%)  8.07 (3.68–17.71)  <0.001 
 Diabetes mellitus 1 (0.7%)  11 (6.8%)  9.90 (1.26–77.69) 0.008 
 Cigarette smoking 45 (33.1%) 42 (26%)  0.71 (0.43–1.17) 0.188 
 Hypercholesterolemia 14 (10.3%) 31 (19.2%)  2.07 (1.05–4.09) 0.032 
 Family history of stroke 21 (15.4%) 15 (9.3%)  0.56 (0.27–1.14) 0.108 
 1  Determined by t test. 
 Table 2. Genotype and allele distribution of p22 phox  in the patient 
and control groups
 Controls (n = 136)  Patients (n = 161) 
 p22 phox  genotype 
 CC 62 (45.6%) 73 (45.3%) 
 CT 68 (50%) 66 (40.9%) 
 TT 6 (4.4%) 22 (13.6%) 
 p22 phox  allele frequency 
 C  192/272 (71%)  212/322 (66%) 
 T 80/272 (29%)  110/322 (34%) 
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ing in an odds ratio of 3.81 (CI 1.38–10.42) for TT carriers 
(unadjusted odds ratio 3.42, CI 1.34–8.75). The T allele 
frequency did not significantly differ between the two 
groups. Heterozygous carriers did not carry an enhanced 
risk of CVD. In analyses of the etiological stroke sub-
groups, our data reveal no clear association with a special 
etiological subgroup ( table 3 ). However, the limited sam-
ple size in the subgroups needs to be accounted for.
 Discussion
 In a well-characterized Caucasian patient and control 
group we have demonstrated a direct, independent asso-
ciation between the p22 phox  C242T polymorphism and 
CVD at a young age. Our findings give further evidence 
that oxidative stress is implicated in the pathogenesis of 
CVD. It remains to be clarified why the reduced oxidative 
stress associated with the T genotype goes along with an 
enhanced risk for CVD, especially when considering pre-
vious studies demonstrating oxidative stress being in-
creased in vascular pathology  [10] . Functionally, an im-
paired NAD(P)H oxidase activity has been linked to 
 enhanced generation of cytotoxic NO derivates (e.g. per-
oxynitrite), abnormal pressor responses  [11] , enhanced 
salt sensitivity  [12] and a procoagulant state  [13] as well 
as postinfarction inflammation and hypercholesterol-
emia  [14] . From our experience of performing genotype 
analysis in a typical population of elderly stroke patients, 
we note that in older subjects weak associations are more 
likely to be masked by the high prevalence of convention-
al vascular risk factors than in a population of juvenile 
patients with a lower burden of risk factors. However, 
even in a young patient population, the conventional vas-
cular risk factors (arterial hypertension, hypercholester-
olemia and diabetes mellitus) are still much more preva-
lent than in the control group ( table 1 ).
 This strategy was also followed by a large Australian 
study with patients aged less than 45 years, which showed 
a higher prevalence of the T allele in young patients with 
coronary artery disease  [5] . Moreover, the etiology for 
ischemic stroke in young people differs from that in the 
elderly, with nonangiopathic causes being more relevant 
 [15] .
 The exact mechanism by which an abnormal reduc-
tion in NAD(P)H oxidase activity may promote vessel pa-
thology, and ultimately result in stroke, still deserves fur-
ther investigation. It should be considered that as well as 
being toxic agents, reactive oxygen species are directly 
implicated    in    adaptive    responses,    including    apoptosis  
 or proliferation of smooth-muscle cells, by modulating 
redox-sensitive gene expression. As the underlying 
pathomechanisms are far from being understood, we 
hope that this report will stimulate further investiga-
tions. 
 Table 3. Etiological subgroups of the study population and the 
frequency of homozygosity for the p22 phox  C242T genotype
 Etiology of cerebral ischemia  Number
 of patients 
 TT genotype
 
 Macroangiopathy  34  7 (20.5%) 
 Microangiopathy 9  0 
 Cardiogenic embolism 1  35  5 (14.2 %) 
 Vasculitis 3  0 
 Dissection  30  5 (16.6%) 
 Cryptogenic  50  5 (10%) 
 The percentage values in parentheses indicate the frequency 
of the TT genotype in each etiological subgroup. 
 1  Includes presumed paradoxic embolism. 
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